- Home
- GERN vs COHU Comparison
GERN vs COHU Comparison
Compare GERN & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- COHU
- Stock Information
- Founded
- GERN 1990
- COHU 1947
- Country
- GERN United States
- COHU United States
- Employees
- GERN N/A
- COHU N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- COHU Electrical Products
- Sector
- GERN Health Care
- COHU Industrials
- Exchange
- GERN Nasdaq
- COHU Nasdaq
- Market Cap
- GERN 853.5M
- COHU 839.8M
- IPO Year
- GERN 1996
- COHU N/A
- Fundamental
- Price
- GERN $1.51
- COHU $18.20
- Analyst Decision
- GERN Buy
- COHU Buy
- Analyst Count
- GERN 7
- COHU 7
- Target Price
- GERN $4.17
- COHU $29.50
- AVG Volume (30 Days)
- GERN 11.3M
- COHU 447.1K
- Earning Date
- GERN 08-07-2025
- COHU 07-30-2025
- Dividend Yield
- GERN N/A
- COHU N/A
- EPS Growth
- GERN N/A
- COHU N/A
- EPS
- GERN N/A
- COHU N/A
- Revenue
- GERN $116,293,000.00
- COHU $390,962,000.00
- Revenue This Year
- GERN $160.12
- COHU $10.84
- Revenue Next Year
- GERN $55.01
- COHU $14.84
- P/E Ratio
- GERN N/A
- COHU N/A
- Revenue Growth
- GERN 22264.04
- COHU N/A
- 52 Week Low
- GERN $1.17
- COHU $12.57
- 52 Week High
- GERN $5.06
- COHU $36.60
- Technical
- Relative Strength Index (RSI)
- GERN 51.36
- COHU 53.28
- Support Level
- GERN $1.42
- COHU $17.84
- Resistance Level
- GERN $1.58
- COHU $18.78
- Average True Range (ATR)
- GERN 0.10
- COHU 0.62
- MACD
- GERN -0.01
- COHU -0.09
- Stochastic Oscillator
- GERN 40.00
- COHU 45.96
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About COHU Cohu Inc.
Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).